The Oncolytic Virus in Cancer Diagnosis and Treatment

Cancer has always been an enormous threat to human health and survival. Surgery, radiotherapy, and chemotherapy could improve the survival of cancer patients, but most patients with advanced cancer usually have a poor survival or could not afford the high cost of chemotherapy. The emergence of oncolytic viruses provided a new strategy for us to alleviate or even cure malignant tumors. An oncolytic virus can be described as a genetically engineered or naturally existing virus that can selectively replicate in cancer cells and then kill them without damaging the healthy cells. There have been many kinds of oncolytic viruses, such as herpes simplex virus, adenovirus, and Coxsackievirus. Moreover, they have different clinical applications in cancer treatment. This review focused on the clinical application of oncolytic virus and predicted the prospect by analyzing the advantages and disadvantages of oncolytic virotherapy.

Abstract licence: CC BY

1. 35.

   The incidence and mortality of major cancers in China, 2012 · 2016

39 more references, whose wording the paper’s licence keeps private.

• Corrected

  Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments · 2023

• Normalization of the tumor microenvironment by harnessing vascular and immune modulation to achieve enhanced cancer therapy · 2023

• Stem cell-based therapy for human diseases · 2022

• Neoantigen: A New Breakthrough in Tumor Immunotherapy · 2021

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.